Valuation
- Market cap
- 2,286,000
- Revenue TTM
- $2,400,000
- Net income TTM
- $-6,540,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -272.50%
- Debt to equity
- 0.00
Trading
- Volume
- 40,000
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- 761,850,000
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Vitasora Health Limited engages in the research, development, and commercialization of medical devices in Australia and the United States. The company offers wheezo device. It is also involved in the production of mobile health applications. In addition, the company provides solutions for managing chronic diseases, including cardiovascular, diabetes, chronic obstructive pulmonary disease, and obesity. The company was...
Show more
Vitasora Health Limited engages in the research, development, and commercialization of medical devices in Australia and the United States. The company offers wheezo device. It is also involved in the production of mobile health applications. In addition, the company provides solutions for managing chronic diseases, including cardiovascular, diabetes, chronic obstructive pulmonary disease, and obesity. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025. The company is headquartered in Melbourne, Australia.
- Industry
- Health Information Services
- Sector
- Healthcare
- Phone
- 61 3 9653 9160
- Website
- https://vitasorahealth.com.au
- Address
- 432 St Kilda Road, Suite 1, Level 9, Melbourne, Australia
Latest news
No headlines yet.
